Best Practices: Applying Extended-Release MAT (or MOUD) in Real-World SettingsPremiere Date: Tuesday, December 31, 2019
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, December 31, 2020
Note: Credit Is No Longer Available
|Genie L. Bailey, MD
Clinical Associate Professor of Psychiatry and Human Behavior
Warren Alpert Medical School of Brown University
Director of Research
Director of Medications for Addiction Division
Stanley Street Treatment and Resources
Fall River, MA
With a recent four-fold increase in diagnoses of opioid use disorder (OUD), mitigating the impact of the opioid epidemic has become more important than ever. New extended-release formulations of agonists and antagonists MAT (medications for OUD or MOUD) options that only require monthly dosing are now available for treating patients with OUD, but education is essential to ensure that providers are able to help their patients transition safely and effectively from dependence to treatment.
The final episode of the three-part CMEOcast podcast series focuses on applying evidence-based strategies to initiating the use of extended-release MOUD in real-world settings, providing best practices for supporting the recovery process of individuals with OUD.
At the end of this CE activity, participants should be able to:
- Apply evidence-based strategies to initiate the use of extended-release medications for opioid use disorder (MOUD) in real-world settings to support the recovery process of individuals with OUD.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Discuss evidence-based strategies to initiate the use of extended-release medications for opioid use disorder (MOUD) in real-world settings to support the recovery process of individuals with OUD.
Supported by an educational grant from Alkermes, Inc.
Primary care physicians, addiction specialists, psychiatrists, nurse practitioners, physician assistants, nurses, and pharmacists.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs) Universal Activity Number:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Bailey reports that she is on the advisory committee for Alkermes; and Camurus AB. She is a consultant for Ostsuka Pharmaceutical & Commercialization Inc.; and Titan Pharmaceuticals, Inc. (unpaid). She receives travel support from Camurus AB.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Kashemi Rorie, PhD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).